Posts tagged "Approved"

Keppra® Approved By FDA For Childhood Seizures

In the U.S., Keppra® has been approved as adjunctive therapy for partial onset seizures in adults and children aged four years and older with epilepsy. However the UCB recently announced that the U.S. Food and Drug Administration (FDA) has now approved to lower the age restriction to include infants from the age of one month and older with epilepsy. Professor Dr. Iris Loew-Friedrich, Chief Medical Officer and Executive Vice President UCB â�¨declared: â�¨”As a leader in epilepsy UCB has a responsibility to develop effective medicines that address unmet medical needs…
Health News from Medical News Today

Cetuximab Approved for Patients with Advanced Head and Neck Cancer

The Food and Drug Administration (FDA) last week approved the targeted drug cetuximab (Erbitux), in combination with chemotherapy, for the treatment of recurrent or metastatic squamous cell carcinoma of the head and neck.
NCI Cancer Bulletin

Byetta (exenatide) Approved In Combination With Glargine For Type 2 Diabetes

Byetta (exenatide) injection has been approved by the FDA as add-on treatment for use with insulin glargine, together with exercise and diet for diabetes type 2 patients who are not responding well enough to glargine alone. Byetta’s add-on therapy is for those on glargine with metformin and/or a TZD (thiazolidinedione) or without. A pivotal study found that with exenatide patients achieved better glycemic control without gaining weight or increased hypoglycemia risk, compared to those on just glargine. John Buse, M.D., Ph.D…
Health News from Medical News Today

Bone Density Drug Approved for Prostate and Breast Cancer Patients

The Food and Drug Administration (FDA) has approved the use of denosumab (Prolia, Xgeva) to increase bone mass in two groups of patients at high risk for fractures: men receiving androgen deprivation therapy for nonmetastatic prostate cancer and women receiving an aromatase inhibitor as post-surgical or adjuvant therapy for breast cancer.
NCI Cancer Bulletin

Nucynta ER Approved For Moderate To Severe Chronic Pain Control

An oral painkiller called Nucynta ER (tapentadol extended-release tablets), has been approved by the U.S. Food and Drug Administration (FDA), Janssen Pharmaceuticals, Inc. announced. The medication is designed to be taken twice daily for the control of moderate to severe chronic pain in adults when a continuous, 24-hour opioid analgesic is needed for an extended period. The immediate-release version of Nucynta was FDA approved in 2008 for the treatment of acute pain in adults aged at least 18 years. Nucynta ER is available in 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths…
Health News from Medical News Today

Development bonds approved for new cancer hospital – Newnan Times-Herald

The Coweta County Development Authority announced at its Thursday meeting the approval of a resolution authorizing the issuance of industrial revenue bonds to assist in the construction of the newest Cancer Treatment Centers of America hospital. “We are …
cancer – Bing News

What You Always Wanted To Know About Adult Acute Lymphoblastic Leukemia (Medical Basic Guides)
“What You Always Wanted To Know About…” are fully researched, straight-to-the-point, easily understandable and most comprehensiv…

What You Need to Know About Acute Myelogenous Leukemia – It’s Your Life, Live It!
As an Oncology Nurse. I had only one protocol in mind while writing this book. That was to show you the most successful cancer tre…

2011 Pediatric Cancer Toolkit: Childhood Non-Hodgkin Lymphoma (NHL), Burkitt, B-Cell, Lymphoblastic Lymphoma (Ringbound Book and DVD-ROM)
This up-to-date and comprehensive ringbound book and DVD-ROM disc set provides a superb collection of authoritative documents from…

Sutent Approved For Advanced Pancreatic Neuroendocrine Tumors, USA

Sutent (sunitinib) has been approved by the FDA for treating advanced pancreatic neuroendocrine tumors. Specifically, the medication has been given the green light for patients whose tumors cannot be surgically removed, or for those whose cancer has metastasized. This is the second drug, after Afinitor, to be approved for the same indication this month…
Cancer / Oncology News From Medical News Today

New Electric Brain Cancer Treatment Approved – CalorieLab Calorie Counter News

Forbes (blog)

New Electric Brain Cancer Treatment Approved CalorieLab Calorie Counter News The first brain cancer treatment using electrical energy fields has been approved by the FDA. The portable NovoTTF device, made by Novocure, represents a fourth approach to treatment for brain cancer, reports MSNBC. Before, doctors used three methods: … Brain-cancer device now FDA-approvedLos Angeles Times FDA Approves New Device for Brain Tumor TreatmentWebMD FDA Approves Cancer Killing Electric Hat for Home UseTakePart – Inspiration to Action PCWorld -BusinessWeek -The Associated Press all 310 news articles »

cancer – Google News

New FDA Approved 3-D Mammogram Improves Diagnosis, Doubles Radiation

Globally, breast cancer comprises 10.4% of all cancer incidences among women, making it the most common type of non-skin cancer in women and the fifth most common cause of cancer death. Today in a technologically scientific breakthrough, he U.S. Food and Drug Administration (FDA) approved the first X-ray mammography device that provides three-dimensional images of the breast for breast cancer screening and diagnosis…

Health News from Medical News Today